Boone Capital Management LLC Biogen Inc. Transaction History

Boone Capital Management LLC

  • $386 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$253.3 - $285.89 $8.42 Million - $9.5 Million
33,238 Added 52.86%
96,115 $24.7 Billion
Q2 2023

Aug 14, 2023
BUY
$275.25 - $318.06 $923,463 - $1.07 Million
3,355 Added 5.64%
62,877 $17.9 Billion
Q1 2023

May 15, 2023
BUY
$256.56 - $292.34 $4.54 Million - $5.17 Million
17,679 Added 42.25%
59,522 $16.5 Billion
Q4 2022

Feb 14, 2023
BUY
$252.44 - $306.72 $10.6 Million - $12.8 Million
41,843 New
41,843 $11.6 Billion

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Boone Capital Management LLC Portfolio

Follow Boone Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boone Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boone Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email